Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases

Neuropsychiatric Disease and Treatment

Volumn 9, Issue , 2013, Pages 847-852

  Lasek Bal, Anetta ^a   Puz, Przemysław ^a   Kazibutowska, Zofia ^a  

^a Upper Silesian Heart Center Katowice   (Poland)

Author keywords

Cryptogenic stroke; Factor VIII; Hemostasis; Risk factor

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADULT; ARTICLE; BRAIN ARTERY; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMODYNAMICS; HOSPITALIZATION; HUMAN; MALE; PROTEIN BLOOD LEVEL; RISK FACTOR;

EID: 84879142384     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S43461     Document Type: Article

References (28)

1. Kaufman RJ, Dorner AJ, Fass DN. Von Willebrand factor elevates plasma factor VIII without induction of factor VIII messenger RNA in the liver. Blood. 1999;93(1):193-197.
2. Noe DA. A mathematical model of coagulation factor VIII kinetics. Haemostasis. 1996;26(6):289-303.
3. Pasierski T, Undas A, Zawilska K, Sosnowski C. Leczenie przeci-wzakrzepowe [Anticoagulant therapy]. Medycyna Praktyczna, Kraków 2007.
4. Rosendaal FR, Briët E, Stibbe J, et al. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol. 1990; 75(4):525-530.
5. Srámek A, Kriek M, Rosendaal FR. Decreased mortality of ischae-mic heart disease among carriers of haemophilia. Lancet. 2003; 362(9381):351-354.
6. Koster T, Blann AD, Briët E, Vandenbroucke J P, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345(8943):152-155.
7. Kamphuisen PW, Eikenboom JC, Bertina RM. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol. 2001; 21(5):731-738.
8. Folsom AR, Rosamond WD, Shahar E, et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation. 1999;100(7):736-742.
9. Wattanakit K, Folsom AR, Chambless LE, Nieto FJ. Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2005;149(4):606-612.
10. Zakrzepy i zatory [Blood clots and blockages]. Redakcja Łopaciuk Stanisław. Wydawnictwo Lekarskie PZWL, Warszawa 1996.
11. Kullo IJ, Gau GT, Tajik AJ. Novel risk factors for atherosclerosis. Mayo Clin Proc. 2000;75(4):369-380.
12. Meade T W, Cooper JA, Stirling Y, et al. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol. 1994; 88(3):601-607
13. Folsom AR, Wu KK, Rosamond WD, et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 1997; 96(4):1102-1108.
14. Vormittag R, Simanek R, Ay C, Dunkler D, et al. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study. Arterioscler Thromb Vasc Biol. 2009; 29(12):2176-2181.
15. Rumley A, Lowe GD, Sweetnam PM, et al. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. Br J Haematol. 1999;105(1):110-116.
16. Tracy R P, Arnold AM, Ettinger W, et al. The relationship of fbrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol. 1999;19(7):1776-1783.
17. Cortellaro M, Boschetti C, Cofrancesco E, et al. The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group. Arterioscler Thromb. 1992;12(9):1063-1070.
18. Ruggeri ZM, Zimmerman TS. von Willebrand factor and von Willebrand disease. Blood. 1987;70(4):895-904.
19. Conlan MG, Folsom AR, Finch A, et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost. 1993;70(3):380-385.
20. Blann A. von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci. 1993;50(2):125-134.
21. Pottinger BE, Read RC, Paleolog EM, et al. von Willebrand factor is an acute phase reactant in man. Thromb Res. 1989;53(4):387-394.
22. Bombeli T, Jutzi M, De Conno E, et al. In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fbrinolysis proteins. Blood Coagul Fibrinolysis. 2002;13(7): 577-581.
23. Moskau S, Golla A, Grothe C, et al. Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families. Stroke. 2005;36(1):5-8.
24. Souto JC, Almasy L, Borrell M, et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet. 2000; 67(6):1452-1459.
25. Soria JM, Almasy L, Souto JC, et al. A new locus on chromosome 18 that infuences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility. J Blood. 2003;101(1):163-167.
26. Bank I, Libourel EJ, Middeldorp S, et al. Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. J Thromb Haemost. 2005;3(1):79-84.
27. Kamphuisen P W, Eikenboom JC, Vos HL, et al. Increased levels of factor VIII and fbrinogen in patients with venous thrombosis are not caused by acute phase reactions. Thromb Haemost. 1999;81(5): 680-683.
28. O'Donnell J, Mumford AD, Manning RA, Laffan M. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost. 2000;83(1):10-13.